Madison, Wis. - The Wisconsin Alumni Research Foundation issued the following statement following the rejection of its stem cell patent claims before the European Patent Office. “The Wisconsin Alumni Research Foundation (WARF) is disappointed in the decision of the Enlarged Board of Appeal of the European...
In a remarkable story that has gotten the attention of venture investors, doctors in Europe have given a 30-year-old woman a new windpipe with tissue grown from her own (adult) stem cells, eliminating the need for anti-rejection drugs, writes Inside Wisconsin columnist Tom Still. This...
On the heels of a $500,000 SBIR grant, the Madison-based Cellular Dynamics International announced that it has closed on $18 million in financing led by Tactics II Stem Cell Ventures. CDI, co-founded by UW-Madison stem cell research pioneer James Thomson, also announced that it was...
Madison, Wis. — Dave Franchino, president of the innovation firm Design Concepts, Inc. and one of the founders of Sologear, LLC, will present at "Beyond Firewood: Exploring alternative fuels and energy technologies in humanitarian settings." Beyond Firewood, an international research conference organized by the Women's Commission for...
A prominent University of Wisconsin-Madison researcher has been named to President-elect Barack Obama's transition team. R. Alta Charo, a bioethicist who has served on a federal panel on embryonic stem-cell research and on President Clinton's National Bioethics Advisory Commission, will review health policy for Obama. Read more ...
Citing strategic missteps, the La Jolla, California-based Avalon Portfolio has sent a letter to the board of directors of TomoTherapy, urging the board to consider all available options to stem the fall in the company's stock price, including the sale of the company. Avalon, which...
Cellular Dynamics International, the Madison-based biotechnology company co-founded in 2006 by stem cell research pioneer James Thomson, has received another small business innovation research grant to develop human cardiomyocytes, or heart cells, for drug toxicity screening. The grant, worth nearly $500,000, is the second SBIR...
While he can choose to do so by Executive Order, no act of Congress or Executive Order is needed for Barack Obama to reverse the limitations on federal funding for embryonic stem cell lines, according to a UW professor well versed in scientific law. Professor...
The research community celebrated a key milestone Nov. 6 as the University of Wisconsin-Madison marked the 10th anniversary of the announcement that biologist Jamie Thomson had derived embryonic stem cells from a human blastocyst. A great deal has happened since, including President Bush's decision to...
How much longer will the Midwest dominate the medical device landscape? That's what Yer Biotech Blues columnist Michael Rosen wonders after a recent trip to Switzerland. While 10 of the top 20 medical device companies have their headquarters in the Midwest, growth in the medical...